Our client, a rapidly growing publicly traded biopharmaceutical company based in Montreal, is seeking a Corporate Controller to join its leadership team. The successful candidate will oversee consolidated financial reporting, IFRS compliance, and MD&A preparation, while managing controllers across multiple business units. This individual will play a key role in modernizing the finance function through the standardization and automation of processes.
Responsibilities
- Lead the preparation and review of consolidated financial statements in accordance with IFRS.
- Oversee quarterly and annual external reporting requirements for a publicly traded organization, including MD&A preparation and supporting disclosure documentation.
- Ensure compliance with IFRS, regulatory requirements, and internal financial controls.
- Manage and mentor Controllers across multiple business units, fostering collaboration and accountability.
- Coordinate month-end, quarter-end, and year-end close processes across the organization.
- Partner with external auditors and support audit and regulatory review processes.
- Drive the standardization, optimization, and automation of financial reporting and accounting processes.
- Support integration efforts related to acquisitions and corporate growth initiatives.
- Provide financial analysis and strategic insights to executive leadership to support business decision-making.
- Collaborate cross-functionally with operational and executive teams to improve financial performance and reporting accuracy.
- Contribute to the development of scalable finance processes and systems to support future growth.
Qualifications
- CPA designation required.
- 7+ years of progressive finance and accounting experience.
- Extensive experience with consolidated financial reporting and IFRS.
- Experience preparing MD&A and public company reporting requirements.
- Proven leadership experience managing finance and accounting teams.
- Strong knowledge of internal controls, audit processes, and financial governance.
- Experience in a growth-by-acquisition environment is highly desirable.
- Prior exposure to the pharmaceutical, biotechnology, life sciences, or publicly traded sector is considered an asset.
- Demonstrated experience leading process improvement, standardization, and finance automation initiatives.
- Excellent communication, leadership, and stakeholder management skills.
- Bilingualism (English and French) is considered an asset.
